Abstract
Cardiovascular disease and diabetes are intricately related and influenced by factors within the “exposome”. Distinguishing between correlational and causal risk associations is challenging, especially at exposome scale. Here, we triangulate observational Exposure-Wide Association Study (ExWAS) evidence with “randomized” evidence for the exposome using mendelian randomization (MR) for almost 500 exposures. First, the ExWAS identified 144 significant factors for coronary artery disease (CAD) and 237 for type 2 diabetes (T2D), with 120 shared between both. These factors had modest predictive ability (variance explained) for both phenotypes. However, genetic-based causality was deduced for only 14 factors in CAD and 16 in T2D, with seven implicated in both. Additionally, we found strong concordance of MR-validated findings between prevalent and incident disease associations (85.7% [12/14] for CAD and 87.5% [14/16] for T2D). Most correlational findings pertain to lifestyle factors (particularly diet), but social educational factors are more prominently highlighted among those with causal support.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by NIEHS R01 ES032470, Vranos Foundation, NIDDK R01DK137993, NIEHS U24ES036819.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of Harvard University gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced are available in the Supplements. Individual-level participant are available by permission from the UK Biobank.
